Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Futures in Biotech 69: The Power Of Yeast Genetics

October 19, 2010 12:36 pm | Podcasts | Comments

Hosts: Marc Pelletier and Vincent Racaniello, Ph.D., host of This Week in Virology and This Week in Parasitism, Professor of Microbiology, Columbia University, New York, NY. Looking at one of the most powerful genetic model systems: Saccharomyces cerevisiae. Guest: Malcolm Whiteway, Ph.D...

Experts discuss S-equol data at ninth international symposium on role of soy

October 19, 2010 12:35 pm | by EurekAlert | News | Comments

(Porter Novelli) The latest research into the health effects and safety of a soy-based compound called S-equol was described in presentations by experts at a special session during the Ninth International Symposium on the Role of Soy in Health Promotion and Chronic Disease...

TOPICS:

Tylenol 8 Hour Caplets 50 Count: Recall

October 19, 2010 12:35 pm | by U.S. Food & Drug Administration | News | Comments

Uncharacteristic musty or moldy odor.

Advertisement

Mylan Declares Quarterly Preferred Stock Dividend

October 19, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 19 /- Mylan Inc. (Nasdaq: MYL ) today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per...

TOPICS:

Reportlinker Adds Lung Cancer Drug Futures

October 19, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Lung Cancer Drug Futures http://www.reportlinker.com/p0315763/Lung-Cancer-Drug-Futures.html AN EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING FORMATS TO MEET EVERY INFORMATION...

TOPICS:

Reportlinker Adds Prostate Cancer Drug Futures

October 19, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Prostate Cancer Drug Futures http://www.reportlinker.com/p0315764/Prostate-Cancer-Drug-Futures.html AN EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING FORMATS TO MEET EVERY...

TOPICS:

Reportlinker Adds Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis

October 19, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis...

TOPICS:

PMA Final Decisions for September 2010(2)

October 19, 2010 12:31 pm | by U.S. Food & Drug Administration | News | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for September 2010.

TOPICS:
Advertisement

PMA Final Decisions for September 2010

October 19, 2010 12:30 pm | News | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for September 2010.

Patient dies in Biogen MS drug trial

October 19, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

In a Phase 2 clinical trial, Biogen Idec and Roche reported their multiple sclerosis treatment, ocrelizumab, showed signs of reducing the disease indications – but they also reported that one patient died during the testing.

TOPICS:

Patient Experience Research Grants Awarded

October 19, 2010 11:31 am | by Bio-Medicine.Org | News | Comments

DALLAS, Oct. 19 /- As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues. (Logo:...

TOPICS:

Professional sports persons should drink more water

October 19, 2010 10:35 am | by EurekAlert | News | Comments

(FECYT - Spanish Foundation for Science and Technology) Top sports persons must always perform to their maximum capacity, making them the most vulnerable to the effects of dehydration. Now, a new study conducted by researchers from the Universidad de Castilla la Mancha reveals that...

TOPICS:

Cubist makes $250M notes offer

October 19, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cubist Pharmaceuticals Inc. has announced it will offer up to $250 million aggregate principal amount of its convertible senior notes due 2017.

Healthcare IT firm Carrot Medical raises $1M

October 19, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Carrot Medical LLC, a Boston-based company develops communications systems in healthcare, has raised $1.1 million in an equity offering.

BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors

October 19, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

SEOUL, South Korea, Oct. 19 /- BioMolecular Therapeutics, Inc. (BMT, Inc.), a new Seoul-based RNAi therapeutics company with a proprietary technology designed to reduce significantly deleterious side effects triggered by conventional siRNA, announced that it has launched its global...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading